Vincent M. Coghlan
Oregon Health & Science University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vincent M. Coghlan.
Nature Structural & Molecular Biology | 1999
Marceen G. Newlon; Melinda Roy; Dimitrios Morikis; Zachary E. Hausken; Vincent M. Coghlan; John D. Scott; Patricia A. Jennings
Compartmentalization of signal transduction enzymes into signaling complexes is an important mechanism to ensure the specificity of intracellular events. Formation of these complexes is mediated by specialized protein motifs that participate in protein–protein interactions. The adenosine 3´,5´-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) is localized through interaction of the regulatory (R) subunit dimer with A-kinase-anchoring proteins (AKAPs). We now report the solution structure of the type II PKA R-subunit fragment RIIα(1–44), which encompasses both the AKAP-binding and dimerization interfaces. This structure incorporates an X-type four-helix bundle dimerization motif with an extended hydrophobic face that is necessary for high-affinity AKAP binding. NMR data on the complex between RIIα(1–44) and an AKAP fragment reveals extensive contacts between the two proteins. Interestingly, this same dimerization motif is present in other signaling molecules, the S100 family. Therefore, the X-type four-helix bundle may represent a conserved fold for protein–protein interactions in signal transduction.
Journal of Biological Chemistry | 1996
Zachary E. Hausken; Mark L. Dell'Acqua; Vincent M. Coghlan; John D. Scott
Compartmentalization of the type II cAMP-dependent protein kinase is conferred by interaction of the regulatory subunit (RII) with A-Kinase Anchoring Proteins (AKAPs). The AKAP-binding site involves amino-terminal residues on each RII protomer and is formed through dimerization. A site-directed mutagenesis strategy was utilized to assess the contribution of individual residues in either RII isoform, RIIα or RIIβ, for interaction with various anchoring proteins. Substitution of long-chain or bulky hydrophobic groups (leucines or phenylalanines) for isoleucines at positions 3 and 5 in RIIα decreased AKAP-binding up to 24 ± 3 (n = 8)-fold, whereas introduction of valines had minimal effects. Replacement with hydrophilic residues (serine or asparigine) at both positions abolished AKAP binding. Mutation of proline 6 in RIIα reduced binding for four AKAPs (Ht31, MAP2, AKAP79, and AKAP95) from 2.3 to 20-fold (n = 4) whereas introduction of an additional proline at position 6 in RIIβ increased or conferred binding toward these anchoring proteins. Therefore, we conclude that β-branched side chains at positions 3 and 5 are favored determinants for AKAP-binding and prolines at positions 6 and 7 increase or stabilize RIIα interaction with selected anchoring proteins.
Molecular and Cellular Biochemistry | 1993
Vincent M. Coghlan; Susan E. Bergeson; Lorene K. Langeberg; Gajanan Nilaver; John D. Scott
The cAMP-dependent protein kinase (PKA) regulates a variety of diverse biochemical events through the phosphorylation of target proteins. Because PKA is a multifunctional enzyme with a broad substrate specificity, its compartmentalization may be a key regulatory event in controlling which particular target substrates are phosphorylated. In recent years it has been demonstrated that differential localization of the type II holoenzyme is directed through interaction of the regulatory subunit (RII) with a family ofA-KinaseAnchoringProteins (AKAPs). In this report, we review evidence for PKA compartmentalization and discuss the structural and functional properties of AKAPs.
Neuromolecular Medicine | 2005
Jonathan A. Sayer; Maria Manczak; Lakshmi Akileswaran; P. Hemachandra Reddy; Vincent M. Coghlan
Although expansion of a polyglutamine tract in the huntingtin protein is known to cause Huntington’s disease (HD), there is considerable debate as to how this mutation leads to the selective neuronal loss that characterizes the disease. The observation that mutant huntingtin accumulates in neuronal nuclei has led to the hypothesis that the molecular mechanism may involve the disruption of specific nuclear activities. Recently, several nuclear interaction partners for huntingtin have been identified, including HypA, a splicing factor-like protein of unknown function. Using a yeast two-hybrid screen, we have identified the interaction of HypA with the nuclear scaffold protein NAKAP. Interaction of NAKAP with HypA is specific and occurs both in yeast and in vitro. Deletion-mapping studies indicate that binding occurs via a proline-rich domain in NAKAP with a WW domain of HypA. In cultured cells, NAKAP and HypA localize within the nucleus and copurify with the nuclear matrix. Furthermore, NAKAP associates with HypA from human brain and copurifies with huntingtin protein in brain tissue obtained from HD patients. In HD neurons, NAKAP and mutant huntingtin were colocalized to the nuclear matrix and were found to be components of nuclear aggregates. Hence, the NAKAP-HypA scaffold is a potential nuclear docking site for huntingtin protein and may contribute to the nuclear accumulation of huntingtin observed in HD.
Science | 1995
Vincent M. Coghlan; Ba Perrino; M Howard; Lorene K. Langeberg; James Hicks; Wm Gallatin; John D. Scott
Journal of Biological Chemistry | 1994
Zachary E. Hausken; Vincent M. Coghlan; Cheryl A. Schafer Hastings; Erwin M. Reimann; John D. Scott
Journal of Biological Chemistry | 1994
Vincent M. Coghlan; Lorene K. Langeberg; Anne Fernandez; Ned Lamb; John D. Scott
Journal of Biological Chemistry | 1996
Linda B. Lester; Vincent M. Coghlan; Brian Nauert; John D. Scott
Journal of Biological Chemistry | 2001
Lakshmi Akileswaran; Justin W. Taraska; Jonathan A. Sayer; Jessica M. Gettemy; Vincent M. Coghlan
American Journal of Physiology-renal Physiology | 2001
Inho Jo; Donald T. Ward; Michelle A. Baum; John D. Scott; Vincent M. Coghlan; Timothy G. Hammond; H. William Harris